“We have a pretty good sense that what we want to generate is broadly protective immunity that is durable, ideally for life,” says Wayne Koff, CEO of the non-profit Human Vaccines Project. There’s just one problem: “We don’t know how to do that.”
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
